|
ASND
|
Ascendis Pharma A/S
|
US
|
NASDAQ
|
|
AVTE
|
Aerovate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BLPH
|
Bellerophon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LLY
|
Eli Lilly and Company
|
US
|
NYSE
|
|
LQDA
|
Liquidia Technologies, Inc.
|
US
|
NASDAQ
|
|
PFE
|
Pfizer, Inc.
|
US
|
NYSE
|
|
PHAS
|
PhaseBio Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
US
|
NASDAQ
|
|
RVPH
|
Reviva Pharmaceuticals Holdings, Inc.
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
US
|
NASDAQ
|
|
NPNKF
|
Nippon Shinyaku Co. Ltd
|
US
|
OTC
|
|
PHASQ
|
Phasebio Pharmaceuticals Inc
|
US
|
OTC
|
|
JNJ
|
Johnson & Johnson Co DRC
|
AR
|
BA
|
|
2R3
|
Reata Pharmaceuticals Inc
|
DE
|
F
|
|
0950
|
Lee’s Pharmaceutical Holdings Ltd
|
HK
|
HK
|
|
GIS
|
General Mills Inc
|
DE
|
F
|